Information about Geographic Areas

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Information about Geographic Areas

12. Information about Geographic Areas

The Company operates as a single reportable segment and primarily enables customers to perform both research and clinical testing on its nCounter Analysis System. The Company has one sales force that sells these systems to both research and clinical testing labs, and has launched its first product, nCounter Elements reagents, that can be used for both research and diagnostic testing. In addition, the Company’s Prosigna Breast Cancer Assay is marketed to clinical laboratories. The Company has also entered into a companion diagnostic collaboration with Celgene.

The following table of total revenue is based on the geographic location of the Company’s customers, distributors and collaborators. For sales to distributors, their geographic location may be different from the geographic locations of the ultimate end user. Total revenue by geography was as follows (in thousands):

	Three Months Ended March 31,
	2015		2014
North America	$	7,523	$	5,989
Europe, Middle East & Africa		2,943		1,763
Asia Pacific		1,127		999
Total revenue	$	11,593	$	8,751

Total revenue in the United States was $7.2 million and $5.3 million for the three month periods ended March 31, 2015 and 2014, respectively.

The Company’s assets are primarily located in the United States and not allocated to any specific geographic region. Substantially all of the Company’s long-lived assets are located in the United States.